Secretome and extracellular vesicle signatures in bone marrow-derived mesenchymal stromal cells after expansion in standard and next-generation media
Extracellular Vesicles and Circulating Nucleic Acids · 29.04.2025 · 6 (2) · 195-215
DOI: 10.20517/evcna.2024.99 ↗Kurz gefasst
Fachartikel in der Zeitschrift Extracellular Vesicles and Circulating Nucleic Acids, online erschienen am 29.04.2025. Verfasst von Giulio Grieco und 3 weiteren Autor:innen. Beteiligte Einrichtung: Authors contributed equally. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Aim
Mesenchymal stem cells (MSCs) are a promising therapeutic strategy for osteoarthritis (OA), largely due to their regenerative potential, which is attributed in part to their secretome. The secretome includes soluble factors and extracellular vesicles (EVs). Given that MSCs are sensitive to various culture conditions, this study aims to investigate the effects of different media supplemented with either fetal bovine serum (FBS) (F), platelet lysate (P), or serum/xeno-free (S/X) on the composition and therapeutic potential of the secretome from bone marrow-derived MSCs (BMSCs).
Methods
BMSCs were cultured in F, P, or S/X media, with secretomes collected after starvation. The secretomes were analyzed for soluble factors, EVs, and miRNAs. Inflammatory responses were assessed in an in vitro OA model using inflamed chondrocytes and gene expression was evaluated by qRT-PCR.
Results
The secretomes from all conditions exhibited a similar molecular fingerprint. Proteomic analysis identified 98 common proteins encompassing growth factors and inflammatory mediators. EVs showed similar size and phenotype, with a slight difference in CD44 expression in EVs derived from P-expanded MSCs. Despite the high overall similarity, miRNA profiling identified 13 key players, with subtle differences in the miRNA composition of EVs from FBS-expanded BMSCs. All secretomes exhibited anti-inflammatory effects, with the FBS-expanded secretome showing the most pronounced therapeutic potential.
Conclusion
The secretomes derived from different culture conditions share key molecular components. EVs may contribute to variations in therapeutic outcomes through their cargo. Optimizing MSC expansion conditions is crucial for enhancing the therapeutic potential of MSC-derived secretomes in OA treatment. Further research is needed to clarify the specific role of factors, miRNAs, and EVs in modulating OA pathology.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Authors contributed equally.
- Laboratorio di Biotecnologie Applicate all'Ortopedia, IRCCS Ospedale Galeazzi - Sant'Ambrogio, Milano I-20157, Italy.
Zitieren
APA
Grieco, G., Piccolo, S., Ragni, E., & de Girolamo, L. (2025). Secretome and extracellular vesicle signatures in bone marrow-derived mesenchymal stromal cells after expansion in standard and next-generation media. Extracellular Vesicles and Circulating Nucleic Acids, 6(2), 195-215. https://doi.org/10.20517/evcna.2024.99
Vancouver
Grieco G, Piccolo S, Ragni E, de Girolamo L. Secretome and extracellular vesicle signatures in bone marrow-derived mesenchymal stromal cells after expansion in standard and next-generation media. Extracellular Vesicles and Circulating Nucleic Acids. 2025;6(2):195-215. doi:10.20517/evcna.2024.99
BibTeX
@article{Grieco2025,
author = {Grieco, Giulio and Piccolo, Simona and Ragni, Enrico and de Girolamo, Laura},
title = {Secretome and extracellular vesicle signatures in bone marrow-derived mesenchymal stromal cells after expansion in standard and next-generation media},
journal = {Extracellular Vesicles and Circulating Nucleic Acids},
year = {2025},
volume = {6},
number = {2},
pages = {195--215},
doi = {10.20517/evcna.2024.99}
}
EUVIMED